• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Obligation of User Fee Collections

Back to Table of Contents:  FY 2009 MDUFMA Financial Report
 

The user fees collected are expended only for costs necessary to support the process for the review of medical device applications, as defined in MDUFMA.  The allowable and excludable costs for the process for the review of medical device applications are defined in Appendix D.  In FY 2009, FDA obligated $47,302,744 from medical device user fees.  The following table provides a breakout of user fee obligations by expense categories during the past fiscal year.
 

FOOD AND DRUG ADMINISTRATION
FY 2009 MEDICAL DEVICE REVIEW OBLIGATIONS BY EXPENSE CATEGORY
AS OF SEPTEMBER 30, 2009

Expense CategoryFY 2009
Personnel Compensation and Benefits$31,601,700
Travel and Transportation$411,743
GSA Rent$2,056,920
Communications$221,797
Contract Services$10,094,444
Equipment and Supplies$2,792,848
Other (1)$123,292
Total Obligations$47,302,744


 

 

 

 

 

 


 

(1) Other includes expense categories like rent payments to others, printing & reproduction, and other miscellaneous expenses.
 
More information about the costs of the process for device review, as defined in MDUFMA, begins on page 7. 

Next Section:  Carryover Balances